48
purchased the shares pursuant to the 2019 Underwriting Agreement at
a price of
$6.3535 per share. The closing of the offering of
7,000,000 shares of common stock occurred on August 2, 2019, with
net
proceeds to us of approximately $44.2 million after deduction
of underwriting discounts and commissions and other estimated
offering expenses.
On January 23, 2020, we entered into an equity distribution
agreement (the “January
2020 Equity Distribution Agreement”) with
three sales agents pursuant to which we could offer and sell, from
time to time, up to an aggregate amount
of $200,000,000 of shares
of our common stock in transactions that were deemed to be “at the
market”
offerings and privately negotiated transactions.
We issued
a total of 3,170,727 shares under the January 2020 Equity
Distribution Agreement for aggregate
gross proceeds of $19.8 million, and
net proceeds of approximately $19.4 million, after commissions and
fees, prior to
its termination in August 2020.
On August 4, 2020, we entered into an equity distribution agreement
(the “August
2020 Equity Distribution Agreement”) with four
sales agents pursuant to which we could offer and sell, from time
to time, up to an aggregate
amount of $150,000,000 of shares of our
common stock in transactions that were deemed to be “at the market”
offerings and privately
negotiated transactions. We issued a total
of 27,493,650 shares under the August 2020 Equity Distribution
Agreement for
aggregate gross proceeds of approximately $150.0
million, and net proceeds of approximately $147.4 million, after
commissions
and fees, prior to its termination in June 2021.
On January 20, 2021, we entered into an underwriting agreement (the
“January 2021
Underwriting Agreement”) with J.P. Morgan
Securities LLC (“J.P. Morgan”), relating to the offer and sale of
7,600,000 shares of our common stock. J.P.
Morgan purchased the
shares of our common stock from the Company pursuant to the January
2021
Underwriting Agreement at $5.20 per share. In addition,
we granted J.P.
Morgan a 30-day option to purchase up to an additional 1,140,000
shares
of our common stock on the same terms and
conditions, which J.P. Morgan exercised in full on January 21,
2021. The closing of the offering of 8,740,000 shares of our
common
stock occurred on January 25, 2021, with proceeds to us of
approximately $45.2
million, net of offering expenses.
On March 2, 2021, we entered into an underwriting agreement (the
“March 2021 Underwriting
Agreement”) with J.P. Morgan,
relating to the offer and sale of 8,000,000 shares of our common
stock. J.P. Morgan purchased the shares of our common stock
from
the Company pursuant to the March 2021 Underwriting Agreement at
$5.45 per share.
In addition, we granted J.P. Morgan a 30-day
option to purchase up to an additional 1,200,000 shares of our
common stock
on the same terms and conditions, which J.P. Morgan
exercised in full on March 3, 2021. The closing of the offering of
9,200,000 shares of our common
stock occurred on March 5, 2021,
with proceeds to us of approximately $50.0 million, net of offering
expenses.
On June 22, 2021, we entered into an equity distribution agreement
(the “June 2021
Equity Distribution Agreement”) with four
sales agents pursuant to which we could offer and sell, from time
to time, up to an aggregate
amount of $250,000,000 of shares of our
common stock in transactions that were deemed to be “at the market”
offerings and privately
negotiated transactions. We issued a total
of 49,407,336 shares under the June 2021 Equity Distribution
Agreement for aggregate
gross proceeds of approximately $250.0
million, and net proceeds of approximately $246.2 million, after
commissions
and fees,
prior to its termination in October 2021.
On October 29, 2021, we entered into an equity distribution
agreement (the “October
2021 Equity Distribution Agreement”) with
four sales agents pursuant to which we may offer and sell, from
time to time, up to an aggregate
amount of $250,000,000 of shares of
our common stock in transactions that are deemed to be “at the
market” offerings and privately negotiated
transactions. Through
December 31, 2021, we issued a total of 15,835,700 shares under the
October 2021 Equity
Distribution Agreement for aggregate gross
proceeds of approximately $78.3 million, and net proceeds of
approximately
$77.0 million, after commissions and fees.
Stock Repurchase Program
On July 29, 2015, the Company’s Board of Directors authorized the
repurchase of up to 2,000,000
shares of our common stock.
The timing, manner, price and amount of any repurchases is
determined by the Company in its discretion and is subject
to economic
and market conditions, stock price, applicable legal requirements
and other factors.
The authorization does not obligate the Company
to acquire any particular amount of common stock and the program
may
be suspended or discontinued at the Company’s discretion